Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;17(2):161-170.
doi: 10.22037/ghfbb.v17i2.2888.

Acute-on-chronic liver failure; prevalence, causes, predisposing factors, and outcome

Kamran Bagheri Lankarani  1 , Zahra Ghanbarinasab  2 , Ramin Niknam  2
Affiliations

Acute-on-chronic liver failure; prevalence, causes, predisposing factors, and outcome

Kamran Bagheri Lankarani et al. Gastroenterol Hepatol Bed Bench. 2024.

Abstract

Aim: Until now, there has been disagreement regarding the prevalence, causes, predisposing factors, and outcome of ACLF (Acute-on-chronic liver failure). As a result, we have undertaken this research study.

Background: ACLF is a complex syndrome with a poor prognosis.

Methods: In this cross-sectional study, we evaluated the prevalence, causes, predisposing factors, and outcomes of adult cirrhotic patients with ACLF and acute decompensation (AD). ACLF was defined based on the criteria established by APASL (Asian Pacific Association for the Study of the Liver). The severity of organ failure was assessed using both EASL-CLIF (European Association for the Study of the Liver- Chronic Liver Failure) and NACSELD (North American Consortium for the Study of End-Stage Liver Disease) scores. To investigate the impact of different independent variables on mortality, survival analysis methods were used.

Results: A total of 156 patients' data were analyzed in this study. The mean age of patients with ACLF (56.62±16.19 years) was significantly lower compared to the AD group (62.30±14.28 years). Nonalcoholic steatohepatitis and infection were the most common causes and predisposing factors in both AD and ACLF groups, respectively, but the difference between the two groups was not statistically significant. The most common organ failures observed were hepatic encephalopathy and respiratory failure. The probability of death at any given time for was significantly higher in ACLF patients than in the AD group (log rank test; P<0.001). The results of Cox regression analysis revealed that low blood pressure (HR 0.97; 95% CI 0.96-0.99; P<0.001) and decreased blood pH (HR 0.53; 95% CI 0.28-0.99; P=0.04) were significant risk factors associated with increased mortality.

Conclusion: ACLF patients had a lower average age and higher mortality rates compared to AD. Nonalcoholic steatohepatitis was found to be the most common underlying disease in ACLF patients, while infections were identified as the predominant predisposing factor. All cases of mortality in the ACLF group were categorized as grade 3 and 4 based on the EASL-CLIF severity score. Hemodynamic instability and metabolic acidosis emerged as the most significant risk factors associated with increased mortality.

Keywords: APASL; Acute decompensated cirrhosis; Acute-on-chronic liver failure; EASL-CLIF; NACSELD.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Kaplan–Meier chart for probability of death at any time in acute decompensation (AD, n=85) versus acute-on-chronic liver failure (ACLF, n=71)
See this image and copyright information in PMC

Similar articles

  • EASL-CLIF criteria outperform NACSELD criteria for diagnosis and prognostication in ACLF.
    Li F, Thuluvath PJ. Li F, et al. J Hepatol. 2021 Nov;75(5):1096-1103. doi: 10.1016/j.jhep.2021.05.033. Epub 2021 Jun 5. J Hepatol. 2021. PMID: 34102198
  • The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure.
    Wong F, Reddy KR, Tandon P, Lai JC, Jagarlamudi N, Weir V, Kok B, Kalainy S, Srisengfa YT, Albhaisi S, Reuter B, Acharya C, Shaw J, Thacker LR, Bajaj JS. Wong F, et al. Liver Transpl. 2022 Apr;28(4):560-570. doi: 10.1002/lt.26311. Epub 2021 Nov 9. Liver Transpl. 2022. PMID: 34564944
  • Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes.
    Xia L, Qiao ZY, Zhang ZJ, Lv ZC, Tong H, Tong Y, Wu HX, Chen XS, Sun HY, Zhang JJ, Thasler WE, Feng H, Xia Q. Xia L, et al. EClinicalMedicine. 2022 Jun 4;49:101476. doi: 10.1016/j.eclinm.2022.101476. eCollection 2022 Jul. EClinicalMedicine. 2022. PMID: 35747194 Free PMC article.
  • Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.
    Choudhury A, Kulkarni AV, Arora V, Soin AS, Dokmeci AK, Chowdhury A, Koshy A, Duseja A, Kumar A, Mishra AK, Patwa AK, Sood A, Roy A, Shukla A, Chan A, Krag A, Mukund A, Mandot A, Goel A, Butt AS, Sahney A, Shrestha A, Cárdenas A, Di Giorgio A, Arora A, Anand AC, Dhawan A, Jindal A, Saraya A, Srivastava A, Kumar A, Kaewdech A, Pande A, Rastogi A, Valsan A, Goel A, Kumar A, Singal AK, Tanaka A, Coilly A, Singh A, Meena BL, Jagadisan B, Sharma BC, Lal BB, Eapen CE, Yaghi C, Kedarisetty CK, Kim CW, Panackel C, Yu C, Kalal CR, Bihari C, Huang CH, Vasishtha C, Jansen C, Strassburg C, Lin CY, Karvellas CJ, Lesmana CRA, Philips CA, Shawcross D, Kapoor D, Agrawal D, Payawal DA, Praharaj DL, Jothimani D, Song DS, Kim DJ, Kim DS, Zhongping D, Karim F, Durand F, Shiha GE, D'Amico G, Lau GK, Pati GK, Narro GEC, Lee GH, Adali G, Dhakal GP, Szabo G, Lin HC, Li H, Nair HK, Devarbhavi H, Tevethia H, Ghazinian H, Ilango H, Yu HL, Hasan I, Fernandez J, George J, Behari J, Fung J, Bajaj J, Benjamin J, Lai JC, Jia J, Hu JH, Chen JJ, Hou JL, Yang JM, Chang J, Trebicka J, Kalf JC, Sollano JD, Varghese J, Arab JP, Li J, Reddy KR, Raja K, Panda K, Kajal K, Kumar K, Madan K, Kalista KF, Thanapirom K, Win K… See abstract for full author list ➔ Choudhury A, et al. Hepatol Int. 2025 Feb;19(1):1-69. doi: 10.1007/s12072-024-10773-4. Epub 2025 Feb 17. Hepatol Int. 2025. PMID: 39961976 Free PMC article. Review.
  • Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment.
    Zaccherini G, Weiss E, Moreau R. Zaccherini G, et al. JHEP Rep. 2020 Sep 2;3(1):100176. doi: 10.1016/j.jhepr.2020.100176. eCollection 2021 Feb. JHEP Rep. 2020. PMID: 33205036 Free PMC article. Review.
See all similar articles

References

    1. Bajaj JS, O'Leary JG, Lai JC, Wong F, Long MD, Wong RJ, et al. Acute-on-chronic liver failure clinical guidelines. Am J Gastroenterol. 2022;117:225–52. - PubMed
    1. Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382:2137–45. - PubMed
    1. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–37. - PubMed
    1. Claria J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64:1249–64. - PubMed
    1. Fernandez J, Acevedo J, Wiest R, Gustot T, Amoros A, Deulofeu C, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2018;67:1870–80. - PubMed

LinkOut - more resources